Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic inflammatory bowel disease--current status].

J R Madsen1, L S Laursen, K Lauritsen

  • 1Medicinsk gastroenterologisk afdeling, Hvidovre Hospital, København.

Ugeskrift for Laeger
|August 10, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human seizures couple across spatial scales through travelling wave dynamics.

Nature communications·2017
Same author

Low-energy cross-section calculations of single molecules by electron impact: a classical Monte Carlo transport approach with quantum mechanical description.

Physics in medicine and biology·2014
Same author

Recommendations for New Trials of Currently Available Therapy by the IOIBD Task Force on Clinical Trials*.

Inflammatory bowel diseases·2013
Same author

Drug Trials in Inflammatory Bowel Diseases 1993-1995: A Survey Conducted by the IOIBD.

Inflammatory bowel diseases·2013
Same author

Language lateralization represented by spatiotemporal mapping of magnetoencephalography.

AJNR. American journal of neuroradiology·2012
Same author

Autonomic changes with seizures correlate with postictal EEG suppression.

Neurology·2012
Same journal

[Mosaicism as a cause of Cowden syndrome].

Ugeskrift for laeger·2026
Same journal

[Thyrotoxic crisis with cardiogenic shock].

Ugeskrift for laeger·2026
Same journal

[Mindfulness-based cognitive therapy in the treatment of depression].

Ugeskrift for laeger·2026
Same journal

[Fitness].

Ugeskrift for laeger·2026
Same journal

[Risk of developing cataract related to fluoroscopy].

Ugeskrift for laeger·2026
Same journal

[Obturator hernia with small bowel ileus presenting as hip pain in an elderly woman].

Ugeskrift for laeger·2026
See all related articles

Chronic inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, involves complex immune, genetic, and environmental factors. Current treatments focus on corticosteroids, sulphasalazine, and newer agents like mesalazine and immunosuppressants.

Area of Science:

  • Gastroenterology and Immunology
  • Pathogenesis of Inflammatory Bowel Disease (IBD)
  • Molecular and Genetic Factors in IBD

Context:

  • IBD, encompassing ulcerative colitis (UC) and Crohn's disease (CD), lacks a defined etiology.
  • Diagnosis relies on a synthesis of clinical, radiological, endoscopic, and histopathological findings.
  • Recent research explores immune mechanisms, infectious agents, gut microbiota, diet, genetics, and other factors in IBD pathogenesis.

Purpose:

  • To review the current understanding of IBD pathogenesis.
  • To discuss the multifaceted factors contributing to IBD development.
  • To outline established and emerging therapeutic strategies for IBD.

Summary:

  • IBD pathogenesis involves a complex interplay of genetic predisposition and environmental triggers, leading to dysregulated immune responses.

Related Experiment Videos

  • Key inflammatory mediators include cytokines, complement peptides, and eicosanoids, amplified by free oxygen radicals.
  • Current therapies include corticosteroids, sulphasalazine (SAZ), mesalazine, immunosuppressants (azathioprine, 6-mercaptopurine), and metronidazole for specific conditions.
  • Impact:

    • Provides a comprehensive overview of IBD etiology and pathophysiology.
    • Highlights the therapeutic advancements and challenges in managing IBD.
    • Informs future research directions for novel IBD treatments.